This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Nordic Congress
Life Science Executive Partnering
19-20 May 2026Radisson Blu Scandinavia Hotel, Copenhagen, Denmark
Tickets
Menu
Tickets
keyboard_arrow_right

Day 1 – Tuesday 20th May - CET (Central European Time, GMT+01:00)

keyboard_arrow_leftSearch & Filter
search
Day 1 – Tuesday 20th May - CET (Central European Time, GMT+01:00)
search
07:30 - 08:30
Registration & Breakfast
Showing 1 of 1 Streams
08:30 - 08:35
LSX Welcome Address
  • Nadia Moodie - Portfolio Manager, LSX
08:35 - 08:40
Host Address
  • Eivind Hansen - CEO, Helse Bergen / Haukeland University Hospital
08:40 - 09:20
Lifting Norway’s Life Science Industry to the Global Stage & Spearheading Greater Nordic Collaboration
  • Farzad Abdi-Dezfuli - Founding Partner, Sarsia
  • Lena Nymo Helli - CEO, Norway Health Tech
  • Erik Digman Wiklund - CEO, Circio
  • Leif Rune Skymoen - CEO, Legemiddelindustrien (LMI)
  • Donmienne Leung - Director, AbbVie Ventures
09:20 - 10:00
Catering to the 50% - Funding & Scaling Innovative Solutions in Women's Health
  • Masha Stromme - Co-Chair, PAACS Invest
  • Peter Gulliksen - CEO, Nørs
  • Chelsea Ranger - Founder & Chair, Women in Life Science Norway (WiLD Norway)
  • Alina Levchuk - Head of Investor Relations, Ipsen
  • Malin Frithiofsson - CEO, Daya Ventures
10:00 - 10:40
Morning Break
Showing 2 of 2 Streams
10:40 - 11:20
Building a Successful Biotech Company in the Nordics – What Does it Take?
  • Ingrid Teigland Akay - Managing Partner, Hadean Ventures
  • Søren Møller - Managing Partner, Seed Investments, Novo Seeds
  • Julie Waras Brogren - Deputy CEO, Ascelia Pharma
  • Zeno Albisser - CEO, Hemispherian
  • Milla Koistinaho - Partner, Innovestor Life Science
11:20 - 12:00
Is the AI Craze Distorting the VC market?
  • Marko Kuisma - Partner, Innovestor
  • Laurens de Vries - Venture Capital Analyst, Heran Partners
  • Bita Sehat - Partner, Trill Impact Ventures
  • Stina Wallmark - Investment Director, Life Sciences, Voima Ventures
  • Barnaby Pickering - Director, 59 North Communications
10:40 - 11:20
How Is the Nordic Ecosystem Supporting Early-Stage Digital Health and Medical Device Startups
  • Ådne Iden Høiland - Director, Eitri Innovation Center & Health Incubato
  • Nicolas Bouchet - Investment Manager, Healthtech Hub Copenhagen
  • Maria Tell - COO & Investment Director, Segulah Medical Acceleration
  • Thomas Unt - Deputy CEO, Smile Venture Hub
  • Miia Kaye - Investment Director, Tesi
  • Katarina Hedbeck - CEO & Co-founder, Interlinked
11:20 - 12:00
Don’t Sink! Creative Financing Measures and Revenue Streams in a Capital Constrained Environment
  • Sana Alajmovic - Co-founder & CEO, Sigrid Therapeutics
  • Markus Dietrich - Senior Investment Associate, Hadean Ventures
  • Katarina Hedbeck - CEO & Co-founder, Interlinked
  • Tamara Alagirova - CEO & Co-founder, MONCYTE Health
  • Sergio Ferreira - Senior Innovation Advisor, Norway Health Tech
12:00 - 13:10
Lunch Break
Showing 3 of 3 Streams
13:10 - 14:00
Bridging the Gap - Translating University Research to Commercial Value
  • Maarit Merla - CEO, Finnish Drug Discovery
  • Alexandra Gylfe - Founding Partner, Nordic Science Investments
  • Alexandra Patriksson - Science Relations Manager, Testa Center
  • Viktor Drvota - CEO, Karolinska Development
  • Willem van Weperen - CEO, Pluvia Biotech
  • Randi Elisabeth Taxt - Senior Advisor, VIS
14:00 - 14:50
TechBio – How to Accelerate Data Driven Life Sciences
  • Howard Read - European Patent Attorney, ACAPO
  • Duleek Ranatunga - CEO, Pear Bio
  • Giovanni Rizzo - Partner, Biotech Fund, Indaco Venture Partners
  • Carlo Kriesi - Co-founder & CEO, Vitroscope
  • Tess Korthout - R&D Innovation Scout, J&J Innovation
13:10 - 13:30
The MedTech Playbook: Success Factors and Pitfalls in MedTech Product Development
  • Kay Gastinger - Head of Inventas Health, Inventas AS
13:30 - 14:10
Scaling Digital Health Beyond the First Generation – Overcoming the Fragmented Markets & Reimbursement Conundrum
  • Marko Kuisma - Partner, Innovestor
  • Marcus Bergler - Advisory Board Member & Jury Head, MEDKAP Investor Association
  • Ann-Kathrin von Knobloch - Digital Health Expert, Flying Health
  • Daniel Amann - CEO, edupression
  • Karin Leire - Investment Director, Segulah Medical Acceleration
14:10 - 14:30
In Estonia, the future of healthcare is digital
  • Sandra Särav - Deputy Secretary General for Economy & Innovation, Ministry of Economic Affairs & Communications of Estonia
  • Sukaina Virji - Director, Camarco
14:30 - 14:50
SpinChip Diagnostics: Insights From A Successful Medtech Exit
  • Ann-Tove Kongsnes - Deputy CEO & Investment Director, Investinor
  • Morten Jurs - CEO, SpinChip Diagnostics
13:10 - 14:10
Workshop: Innovative Routes to the US Public Markets

Unlock new possibilities for accessing the US public markets, and in particular, US Nasdaq. Join Mintz for a workshop exploring innovative routes beyond the conventional IPO. Gain valuable insights into alternative strategies to fuel your company's growth and expansion.

  • Explore strategic alternatives to the traditional IPO process
  • Learn how to navigate different pathways to the US public market
  • Understand how these routes can help you achieve your financial objectives
  • Gain valuable knowledge for your company's public market journey
  • Bill Hicks - Partner, CO-Chair of Securities & Capital Markets Group, Mintz
14:50 - 15:20
Afternoon Break
Showing 2 of 2 Streams
15:20 - 16:10
Looking to the Future - Preparing Your Biotech Company for an IPO
  • Carsten Borring - Head of Listings & Capital Markets, NASDAQ
  • Thomas Hoftvedt - Managing Director, IBD, Head of Healthcare Coverage, DNB Markets & DNB//Back Bay
  • Amanda Hayward - SVP, Global Head of Business Development, Rallybio
  • Julie Waras Brogren - Deputy CEO, Ascelia Pharma
  • Negin Mokhtari - Venture Partner, Luma Group
16:10 - 17:00
Pharma-Biotech Partnerships: A Synergistic Approach to Drug Development
  • Enza Di Modugno - VP Pharma Partnering, Global Head, CVM, Immunology, Infectious Diseases, Roche
  • Nuno Alves - Associate Director, Business Development, Astellas Pharm
  • Lesley Pan - Director, Strategy & Operations, J&J Innovation
  • Ester Caffarel-Salvador - Director of Strategic Innovation, Chiesi USA
  • Alina Levchuk - Head of Investor Relations, Ipsen
15:20 - 15:50
Going Beyond the Hype and Talk – Is Widespread AI Adoption in Healthcare Feasible
  • Torbjørn Furuseth - CEO & Co-founder, DoMore Diagnostics
  • Stina Wallmark - Investment Director, Life Sciences, Voima Ventures
  • Valentin Normand - CEO, Ambr Institute
  • Lisbeth Snede - President, PiCC United (Patient Involvement and Collaboration Community United)
15:50 - 16:40
Keys to Success as a Digital Health & Medtech Startup When Looking to Expand into New Markets
  • Jonas Jendi - COO & Investment Director, Industrifonden
  • Filip Peters - CEO, Acorai
  • Jannik Grodt Schmidt - Head of Healthcare USA, Innovation Norway
  • Thomas Lie Omdahl - CEO, NordicNeuroLab
  • Barnaby Pickering - Director, 59 North Communications
17:00 - 18:30
Networking Reception
NextMay 20 Showcases
Filter
Streams
Formats
Choose Day